Corcept Therapeutics (CORT) Asset Utilization Ratio (2016 - 2025)
Historic Asset Utilization Ratio for Corcept Therapeutics (CORT) over the last 13 years, with Q3 2025 value amounting to 0.91.
- Corcept Therapeutics' Asset Utilization Ratio rose 873.81% to 0.91 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.91, marking a year-over-year increase of 873.81%. This contributed to the annual value of 0.92 for FY2024, which is 1533.06% up from last year.
- Corcept Therapeutics' Asset Utilization Ratio amounted to 0.91 in Q3 2025, which was up 873.81% from 0.87 recorded in Q2 2025.
- Corcept Therapeutics' Asset Utilization Ratio's 5-year high stood at 0.91 during Q3 2025, with a 5-year trough of 0.61 in Q1 2021.
- In the last 5 years, Corcept Therapeutics' Asset Utilization Ratio had a median value of 0.8 in 2023 and averaged 0.77.
- Per our database at Business Quant, Corcept Therapeutics' Asset Utilization Ratio tumbled by 2251.58% in 2021 and then surged by 4092.72% in 2022.
- Over the past 5 years, Corcept Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.73 in 2021, then decreased by 0.77% to 0.72 in 2022, then grew by 10.27% to 0.79 in 2023, then grew by 4.69% to 0.83 in 2024, then grew by 9.76% to 0.91 in 2025.
- Its Asset Utilization Ratio was 0.91 in Q3 2025, compared to 0.87 in Q2 2025 and 0.81 in Q1 2025.